SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D. C. 20549
FORM
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of February 2010
Commission
File Number: 001-06439
SONY
CORPORATION
(Translation
of registrant's name into English)
1-7-1
KONAN, MINATO-KU, TOKYO, 108-0075, JAPAN
(Address
of principal executive offices)
The
registrant files annual reports under cover of Form 20-F.
Indicate
by check mark whether the registrant files or will file annual reports
under
cover of Form 20-F or Form 40-F,
|
Form
20-F X
|
Form
40-F __
|
Indicate
by check mark whether
the registrant by furnishing the information
contained in
this Form
is also thereby furnishing the information to the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934,
Yes No
X
If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection
with Rule 12g3-2(b):82-______
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act
of 1934, the registrant has
duly caused this report to be signed on
its behalf by the undersigned,
thereunto duly authorized.
|
SONY
CORPORATION
|
|
|
(Registrant)
|
|
|
By: /s/ Nobuyuki
Oneda
|
|
|
(Signature)
|
|
|
Nobuyuki
Oneda
|
|
|
Executive Deputy
President and
|
|
|
Chief
Financial Officer
|
Date:
February 10, 2010
List of
materials
Documents
attached hereto:
i) Press
release entitled "Sony
Enters the Flow Cytometry Business in Life Science Field by Acquiring
iCyt"
|
News &
Information
|
Sony
Corporation
Konan
1-7-1, Minato-ku, Tokyo
|
No.
10-021E
February
10, 2010
Sony
Enters the Flow Cytometry Business in Life Science Field by Acquiring
iCyt
Sony Corporation (Sony) announced today that it has
acquired iCyt Mission Technology, Inc. (iCyt), a leading producer of
high-performance cell sorters used for stem cell and disease research, through
its U.S. subsidiary, Sony Corporation of America (SCA). With this
acquisition, Sony is applying its expertise and technologies to enter the flow
cytometry business in the life science field. iCyt, founded in 1995
and headquartered in Champaign, Illinois, designs,
manufactures and sells flow cytometers, associated reagents and
services.
“Sony brings an amazing level of technology and engineering
capability to the field of cytometry,”
said Gary Durack, founder, President & CEO of iCyt. “As
a Sony company, iCyt will be able to leverage Sony’s global resources to deliver
a variety of innovative solutions to the cell analysis market. This
is truly a win for iCyt, its customers, and all who will benefit from these
advances.”
“We are very pleased to welcome Gary Durack,
who has extensive experience in the flow cytometry industry, and iCyt to the
Sony family,” said Keiji Kimura, EVP of Sony.
“iCyt’s experience and technologies will be valuable assets for Sony as it
enters into the rapidly evolving life science field. We are confident
that this acquisition will accelerate the development of Sony’s flow cytometry
business by combining Sony’s expertise in the manufacturing of electronics
products for consumers and professionals with the technological assets of
iCyt.”
As a wholly-owned subsidiary of SCA, iCyt plans to develop
advanced technologies and deliver new products in collaboration with
Sony. Gary Durack will continue to lead the company through this
period of growth and expansion.
New products and advancements will be announced at CYTO
2010 (www.cytoconference.org),
the upcoming Congress of the International Society for Advancement of Cytometry
(ISAC), in Seattle in May 2010.
Sony has
been exploring healthcare applications for its consumer-based optic
technologies, such as those used for Blu-ray discs and its advanced data
processing technologies. Recent progress in regenerative medicine has
highlighted the importance of cell analysis and, specifically, flow cytometry,
an indispensable tool for research. Sony plans to realize unique
technological advances in flow cytometry through the application of its core
technologies. As part of this effort, Sony and iCyt have been jointly
developing new flow cytometry devices since April 2009. Through this
acquisition, Sony expects to accelerate its development of next-generation cell
analysis systems and deliver innovative products to research and clinical
laboratories around the world.
About Sony
Corporation:
Sony
Corporation is a leading manufacturer of audio, video, game, communications, key
device and information technology products for the consumer and professional
markets. With its music, pictures, computer entertainment and on-line
businesses, Sony is uniquely positioned to be the leading electronics and
entertainment company in the world. Sony recorded consolidated annual
sales of approximately $79 billion for the fiscal year ended March 31,
2009. Sony Global Web Site: http://www.sony.net/
About
iCyt:
iCyt
supplies advanced flow cytometry analysis and sorting technology for use in life
science research. Its products are marketed to private and public
research institutions, pharmaceutical and biotechnology companies, and large
medical centers. iCyt has received significant industry recognition
for its line of multi-channel, high-speed cell sorting products. iCyt
Web Site: http://www.i-cyt.com/
Media
Inquiries:
Corporate
Communications, Sony Corporation
Tel:
+81-3-6748-2200